Long-Term Oxygen Therapy (LTOT)

Treatment for Copd

Typical Dosage: 1-4 L/min via nasal cannula

Effectiveness

90%

Safety Score

90%

Clinical Trials

Participants

Comparative Safety Scale(Higher is safer)

Cyanide☠️

Meth💀

Cigarettes🚬

Chemo☢️

Alcohol🍺

Morphine💊

Antibiotics💉

Tylenol💊

Exercise🏃

Water💧

DangerousModerateSafe

Treatment Details

Dosage Range

1-4 L/min via nasal cannula

Time to Effect

Immediate (physiological), 6-12 months (survival)

Treatment Duration

Lifetime

Evidence Quality

HIGH

Number Needed to Treat (NNT)

5(Treat 5 patients to see 1 additional successful outcome)

Confidence Score

98%confidence in effectiveness data

Health Economics

Annual Cost of Care

Drug Cost:$4,500

Monitoring:$300

Side Effect Mgmt:$50

Total Annual:$4,850

Cost-Effectiveness Analysis

Cost-Effectiveness Rating

EXCELLENT

ICER

$25,000/QALY

QALYs Gained

0.2

Outcome-Based Costs

Cost per Responder

$6,929

Comparison vs No Oxygen Therapy

Cost Difference

+$4,850/year

More expensive

QALY Difference

+0.20 QALYs

Better outcomes

Dominance

No dominance

Prescription Access Economics

Annual Societal Loss per Patient

$-9,410

Cost of prescription-only barriers (visits, time, admin, price premium)

Physician Visit Cost

$360/year

Time Cost

$180/year

Travel + wait time

Insurance Admin Cost

$50/year

Prior auth, claims

Risk Assessment

Misuse Risk

MODERATE

Missed Diagnosis Risk

LOW

Requires Monitoring

Yes

Needs lab work/checkups

Long-Term Oxygen Therapy (LTOT) Outcomes

for Copd

Efficacy Outcomes

Overall Effectiveness

+90%

Response Rate

+70%

Common Side Effects

Dry nasal passages

+20%

Skin irritation from cannula

+10%

Fire hazard

+0.1%

Sources:

researcher.life

nih.gov

springermedizin.de

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials

4 active trials recruiting for Long-Term Oxygen Therapy (LTOT) in Copd

Home High Flow Oxygen to Reduce Acute Exacerbation of COPD

NCT05196698RECRUITINGNA

View Study

406 participants

INTERVENTIONAL

Rouen, France

Started: Aug 26, 2022

The ROAM Research Study Therapy (LTOT) Version

NCT06810323RECRUITING

View Study

100 participants

OBSERVATIONAL

Charlottesville, United States

Started: Jan 14, 2025

Impact of Home Non Invasive Ventilation in Patients With Chronic Obstructive Pulmonary Disease Discharged From Assiut University Hospital

NCT07198880NOT YET RECRUITINGNA

View Study

40 participants

INTERVENTIONAL

Started: Jan 1, 2026

Effects of Pulmonary Diseases and Their Treatment on Cardiac Function

NCT05042219RECRUITING

View Study